BridgeMD
Continuous Wound Infiltration versus placebo following elective minimally invasive colorectal surgery; a double-blinded, randomised, placebo-controlled, low-intervention trial (CIMICS trial)
EU CTIS ID: 2024-512107-39-00
What this study is testing
To determine the effect of continuous wound infusion with local analgesics on post-operative recovery for patients who underwent minimally invasive colorectal surgery
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 18 years or older
- Scheduled for minimally invasive colorectal surgery
- Provided written informed consent
You likely can't join if
- Any contra-indication to the CWI system or allergies for the used local analgesic
- Inflammatory Bowel Disease: ulcerative colitis or Crohn’s disease
- Emergency surgery
- Chronic opioid consumption (i.e. daily use for at least 90 days), or active drug addiction
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.